美国 · SEC FORM 4
Sensus Healthcare, Inc.
SRTS · Nasdaq · CIK 0001494891 · Healthcare · Medical Devices
内部人信号
2 位买方 · 9 条买入交易行 · $568.5K 买入总额
为什么有这个信号?
评分构成
每条进度条表示其对当前分数的贡献;权重和公式保持不变。
哪些因素限制了当前分数?
- ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
- ⚠ 角色得分低 · 买入者中职位最高的是:CHIEF EXECUTIVE OFFICER(CEO、董事长和持股 10% 以上的股东得分最低)
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后,不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: CHIEF EXECUTIVE OFFICER, Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 57.2
- 57.0
- 56.9
- 56.8
- 56.6
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- -5.4%
- 3M
- -4.2%
- 6M
- -34.3%
- 12M
- -14.5%
波动率与流动性
- 波动率
- 69.7%
- Beta
- —
- 平均每日成交额
- USD 85,803
估值
- 市值
- USD 48.6M
- P/E
- —
基本面
- 利润率
- -28.1%
- ROE
- -16.0%
- 细分行业
- Medical Devices
市场数据
价格数据截至:2026-10-11 · 价格来源:OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件:市值, 利润率, ROE · 财年截止日:2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期:2026-08-10 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 227,582
- 上期报告
- 227,209
- 日均成交量
- 29,017
- 回补天数
- 7.8
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | Sachetta Eric | 买入 (P) | Common Stock | 27,304 | USD 3.54 | USD 96,656 | SEC 申报 ↗ |
| 2026-08-28 | Sachetta Eric | 买入 (P) | Common Stock | 37,537 | USD 3.44 | USD 129,127 | SEC 申报 ↗ |
| 2026-08-27 | Sachetta Eric | 买入 (P) | Common Stock | 10,925 | USD 3.18 | USD 34,742 | SEC 申报 ↗ |
| 2026-08-26 | Sachetta Eric | 买入 (P) | Common Stock | 9,708 | USD 3.29 | USD 31,939 | SEC 申报 ↗ |
| 2026-08-24 | Sachetta Eric | 买入 (P) | Common Stock | 34,697 | USD 3.25 | USD 112,765 | SEC 申报 ↗ |
| 2026-08-21 | Sachetta Eric | 买入 (P) | Common Stock | 7,000 | USD 3.25 | USD 22,750 | SEC 申报 ↗ |
| 2026-08-20 | Sardano Joseph C | 买入 (P) | Common Stock | 20,000 | USD 3.02 | USD 60,400 | SEC 申报 ↗ |
| 2026-08-20 | Sachetta Eric | 买入 (P) | Common Stock | 24,000 | USD 3.13 | USD 75,120 | SEC 申报 ↗ |
| 2026-05-12 | Sachetta Eric | 买入 (P) | Common Stock | 1,500 | USD 3.34 | USD 5,010 | SEC 申报 ↗ |
| 2026-02-24 | Sachetta Eric | 买入 (P) | Common Stock | 2,000 | USD 3.81 | USD 7,620 | SEC 申报 ↗ |
| 2025-11-21 | Sachetta Eric | 买入 (P) | Common Stock | 7,000 | USD 3.93 | USD 27,510 | SEC 申报 ↗ |
| 2025-11-18 | Sardano Michael | 买入 (P) | Common Stock | 1,000 | USD 3.80 | USD 3,800 | SEC 申报 ↗ |
| 2025-11-18 | Sardano Joseph C | 买入 (P) | Common Stock | 25,000 | USD 4.03 | USD 100,750 | SEC 申报 ↗ |
| 2025-11-13 | Sachetta Eric | 买入 (P) | Common Stock | 2,500 | USD 4.50 | USD 11,250 | SEC 申报 ↗ |
| 2025-11-11 | Sardano Michael | 买入 (P) | Common Stock | 2,000 | USD 4.27 | USD 8,546 | SEC 申报 ↗ |
Form 4 申报证据
22 transaction lines in the latest 365-day window; 119 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | Sachetta Eric | 买入 (P) | Common Stock | 27,304 | USD 3.54 | USD 96,656 | SEC 申报 ↗ |
| 2026-08-28 | Sachetta Eric | 买入 (P) | Common Stock | 37,537 | USD 3.44 | USD 129,127 | SEC 申报 ↗ |
| 2026-08-27 | Sachetta Eric | 买入 (P) | Common Stock | 10,925 | USD 3.18 | USD 34,742 | SEC 申报 ↗ |
展开近期 Form 4 证据 (18 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | Sachetta Eric | 买入 (P) | Common Stock | 27,304 | USD 3.54 | USD 96,656 | SEC 申报 ↗ |
| 2026-08-28 | Sachetta Eric | 买入 (P) | Common Stock | 37,537 | USD 3.44 | USD 129,127 | SEC 申报 ↗ |
| 2026-08-27 | Sachetta Eric | 买入 (P) | Common Stock | 10,925 | USD 3.18 | USD 34,742 | SEC 申报 ↗ |
| 2026-08-26 | Sachetta Eric | 买入 (P) | Common Stock | 9,708 | USD 3.29 | USD 31,939 | SEC 申报 ↗ |
| 2026-08-24 | Sachetta Eric | 买入 (P) | Common Stock | 34,697 | USD 3.25 | USD 112,765 | SEC 申报 ↗ |
| 2026-08-21 | Sachetta Eric | 买入 (P) | Common Stock | 7,000 | USD 3.25 | USD 22,750 | SEC 申报 ↗ |
| 2026-08-20 | Sardano Joseph C | 买入 (P) | Common Stock | 20,000 | USD 3.02 | USD 60,400 | SEC 申报 ↗ |
| 2026-08-20 | Sachetta Eric | 买入 (P) | Common Stock | 24,000 | USD 3.13 | USD 75,120 | SEC 申报 ↗ |
| 2026-05-12 | Sachetta Eric | 买入 (P) | Common Stock | 1,500 | USD 3.34 | USD 5,010 | SEC 申报 ↗ |
| 2026-02-24 | Sachetta Eric | 买入 (P) | Common Stock | 2,000 | USD 3.81 | USD 7,620 | SEC 申报 ↗ |
| 2025-12-12 | Sardano Michael | 奖励/授予 (A) | Common Stock | 40,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-21 | Sachetta Eric | 买入 (P) | Common Stock | 7,000 | USD 3.93 | USD 27,510 | SEC 申报 ↗ |
| 2025-11-18 | Sardano Michael | 买入 (P) | Common Stock | 1,000 | USD 3.80 | USD 3,800 | SEC 申报 ↗ |
| 2025-11-18 | Sardano Joseph C | 买入 (P) | Common Stock | 25,000 | USD 4.03 | USD 100,750 | SEC 申报 ↗ |
| 2025-11-13 | Sachetta Eric | 买入 (P) | Common Stock | 2,500 | USD 4.50 | USD 11,250 | SEC 申报 ↗ |
| 2025-11-11 | Sardano Michael | 买入 (P) | Common Stock | 2,000 | USD 4.27 | USD 8,546 | SEC 申报 ↗ |
| 2025-11-11 | Sardano Michael | 买入 (P) | Common Stock | 2,000 | USD 4.26 | USD 8,523 | SEC 申报 ↗ |
| 2025-11-11 | Sardano Michael | 买入 (P) | Common Stock | 1,000 | USD 4.26 | USD 4,260 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | SRTS |
| CIK | 0001494891 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 119 transaction lines from 2020-02-01 to 2026-08-31 45 P purchase lines · 37 S sale lines · 37 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.